Yi-Li Ma
机构：Third Affiliated Hospital of Southern Medical University, Southern Medical University
发表论文 7 篇 · 总被引 37 次 · h-index 3
代表论文
- Tertiary lymphoid structures in HCC: Influence on immune cell profiles in tumors and on efficacy of adjuvant PD-1 inhibitor therapy after hepatectomy (2025 · Hepatology · 被引 15)
- Treatment Duration of Adjuvant Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Patients at High Risk of Recurrence after Resection: A Prospective, Multicentric Cohort Study (2024 · Liver Cancer · 被引 14)
- Prognostic value of radiological and pathological complete response following immune-based conversion therapy in patients with unresectable hepatocellular carcinoma (GUIDANCE004) (2025 · JHEP Reports · 被引 7)
- Construction of TLS-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma (2026 · Hepatology Communications · 被引 1)
- Erratum: Tertiary lymphoid structures in hepatocellular carcinoma: influence on immune cell profiles in tumors and on efficacy of adjuvant PD-1 inhibitor therapy after hepatectomy (2026 · Hepatology)
- Sintilimab as adjuvant therapy for high-risk hepatocellular carcinoma after curative resection: a multicentric retrospective cohort study (2025 · European Journal of Gastroenterology & Hepatology)